John P Sharp - Net Worth and Insider Trading
John P Sharp Net Worth
The estimated net worth of John P Sharp is at least $2 Million dollars as of 2024-07-17. John P Sharp is the VP Finance and CFO of Ligand Pharmaceuticals Inc and owns about 17,667 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $2 Million. John P Sharp is also the CFO and Secretary of PhaseBio Pharmaceuticals Inc and owns about 5,000 shares of PhaseBio Pharmaceuticals Inc (PHASQ) stock worth over $1. Details can be seen in John P Sharp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John P Sharp has not made any transactions after 2018-12-07 and currently still holds the listed stock(s).
Transaction Summary of John P Sharp
John P Sharp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John P Sharp owns 3 companies in total, including PhaseBio Pharmaceuticals Inc (PHASQ) , Ligand Pharmaceuticals Inc (LGND) , and Sequenom Inc (SQNM) .
Click here to see the complete history of John P Sharp’s form 4 insider trades.
Insider Ownership Summary of John P Sharp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PHASQ | PhaseBio Pharmaceuticals Inc | 2020-02-12 | Chief Financial Officer |
| LGND | Ligand Pharmaceuticals Inc | 2014-02-12 | VP Finance and CFO |
| SQNM | Sequenom Inc | 2007-01-18 | Treasurer |
John P Sharp Latest Holdings Summary
John P Sharp currently owns a total of 2 stocks. Among these stocks, John P Sharp owns 17,667 shares of Ligand Pharmaceuticals Inc (LGND) as of February 12, 2014, with a value of $2 Million and a weighting of 100%. John P Sharp also owns 5,000 shares of PhaseBio Pharmaceuticals Inc (PHASQ) as of December 7, 2018, with a value of $1 and a weighting of 0%.
Latest Holdings of John P Sharp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2014-02-12 | 17,667 | 98.95 | 1,748,150 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 2018-12-07 | 5,000 | 0.00 | 1 |
Holding Weightings of John P Sharp
John P Sharp Form 4 Trading Tracker
According to the SEC Form 4 filings, John P Sharp has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 86,953 shares on February 12, 2014, which brought John P Sharp around $6 Million.
According to the SEC Form 4 filings, John P Sharp has made a total of 0 transactions in PhaseBio Pharmaceuticals Inc (PHASQ) over the past 5 years. The most-recent trade in PhaseBio Pharmaceuticals Inc is the acquisition of 5,000 shares on December 7, 2018, which cost John P Sharp around $19,200.
Insider Trading History of John P Sharp
- 1
John P Sharp Trading Performance
GuruFocus tracks the stock performance after each of John P Sharp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John P Sharp is -26.65%. GuruFocus also compares John P Sharp's trading performance to market benchmark return within the same time period. The performance of stocks bought by John P Sharp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John P Sharp's insider trading performs compared to the benchmark.
Performance of John P Sharp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.18 | | | | | |
| Relative Return to S&P 500(%) | -11.01 | | | | | |
John P Sharp Ownership Network
John P Sharp Owned Company Details
What does PhaseBio Pharmaceuticals Inc do?
Who are the key executives at PhaseBio Pharmaceuticals Inc?
John P Sharp is the Chief Financial Officer of PhaseBio Pharmaceuticals Inc. Other key executives at PhaseBio Pharmaceuticals Inc include 10 percent owner New Enterprise Associates 13 Lp , VP & Human Resources Glen Burkhardt , and Chief Commercial Officer Jonathan Birchall .
PhaseBio Pharmaceuticals Inc (PHASQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PhaseBio Pharmaceuticals Inc (PHASQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
PhaseBio Pharmaceuticals Inc Insider Transactions
John P Sharp Mailing Address
Above is the net worth, insider trading, and ownership report for John P Sharp. You might contact John P Sharp via mailing address: 11119 North Torrey Pines Road, Ste 200, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
